Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by IainCaimbeulon Jun 12, 2024 2:51pm
54 Views
Post# 36085406

RE:Board holdings

RE:Board holdings
LithLover wrote: Riggs owns 12.5 million shares, Tripp 3.8 million, Garth 1 million, Harry 1 million  and Health Clinics 12.5 million.

So Tripp's just gonna let the filing pass, get delisted and file for bankruptcy  Riggs would just let 12.5 million shares at .04 or $500,000 be written off.  Rather than loan the company the money to file?

 


Tripp has had 6 weeks to file, so far nothing. If I had to pick one single word to describe Tripp it would be tendentious

If for the sake of argument he gets the auditors paid before 3 July 2024, what then? Surely the board will not keep this utter incompetent on board? 

There is an old saying that company and fish both smell after 3 days. The same applies after 3 years of trying to get Aristotle to market. It stinks to hgh heaven, Tripp has to go, the sooner the better.
<< Previous
Bullboard Posts
Next >>